John W Smither - Net Worth and Insider Trading
John W Smither Net Worth
The estimated net worth of John W Smither is at least $1 Million dollars as of 2024-06-06. John W Smither is the CFO of Arcutis Biotherapeutics Inc and owns about 133,036 shares of Arcutis Biotherapeutics Inc (ARQT) stock worth over $1 Million. John W Smither is also the Director of Genelux Corp and owns about 6,920 shares of Genelux Corp (GNLX) stock worth over $17,438. Details can be seen in John W Smither's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that John W Smither has not made any transactions after 2023-09-13 and currently still holds the listed stock(s).
Transaction Summary of John W Smither
John W Smither Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John W Smither owns 7 companies in total, including Arcutis Biotherapeutics Inc (ARQT) , Principia Biopharma Inc (PRNB) , and Sienna Biopharmaceuticals Inc (SNNAQ) among others .
Click here to see the complete history of John W Smither’s form 4 insider trades.
Insider Ownership Summary of John W Smither
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ARQT | Arcutis Biotherapeutics Inc | 2021-03-10 | Chief Financial Officer |
| PRNB | Principia Biopharma Inc | 2019-02-19 | director |
| SNNAQ | Sienna Biopharmaceuticals Inc | 2019-01-01 | Chief Financial Officer |
 | | 2018-06-05 | director |
| | 2022-01-27 | director |
| | 2020-08-25 | director |
| | 2023-09-13 | director |
John W Smither Latest Holdings Summary
John W Smither currently owns a total of 2 stocks. Among these stocks, John W Smither owns 133,036 shares of Arcutis Biotherapeutics Inc (ARQT) as of March 10, 2021, with a value of $1 Million and a weighting of 98.3%. John W Smither also owns 6,920 shares of Genelux Corp (GNLX) as of September 13, 2023, with a value of $17,438 and a weighting of 1.7%.
Latest Holdings of John W Smither
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ARQT | Arcutis Biotherapeutics Inc | 2021-03-10 | 133,036 | 7.60 | 1,011,074 |
| GNLX | Genelux Corp | 2023-09-13 | 6,920 | 2.52 | 17,438 |
Holding Weightings of John W Smither
John W Smither Form 4 Trading Tracker
According to the SEC Form 4 filings, John W Smither has made a total of 7 transactions in Arcutis Biotherapeutics Inc (ARQT) over the past 5 years, including 0 buys and 7 sells. The most-recent trade in Arcutis Biotherapeutics Inc is the sale of 1,750 shares on March 10, 2021, which brought John W Smither around $57,575.
According to the SEC Form 4 filings, John W Smither has made a total of 1 transactions in Genelux Corp (GNLX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Genelux Corp is the sale of 900 shares on September 13, 2023, which brought John W Smither around $18,702.
Insider Trading History of John W Smither
- 1
John W Smither Trading Performance
John W Smither Ownership Network
John W Smither Owned Company Details
What does Arcutis Biotherapeutics Inc do?
Who are the key executives at Arcutis Biotherapeutics Inc?
John W Smither is the Chief Financial Officer of Arcutis Biotherapeutics Inc. Other key executives at Arcutis Biotherapeutics Inc include See Remarks Patrick Burnett , SVP and General Counsel Masaru Matsuda , and Chief Commercial Officer Larry Todd Edwards .
Arcutis Biotherapeutics Inc (ARQT) Insider Trades Summary
Over the past 18 months, John W Smither made no insider transaction in Arcutis Biotherapeutics Inc (ARQT). Other recent insider transactions involving Arcutis Biotherapeutics Inc (ARQT) include a net sale of 42,938 shares made by Todd Franklin Watanabe , a net sale of 91,496 shares made by Patrick Burnett , and a net sale of 15,665 shares made by Masaru Matsuda .
In summary, during the past 3 months, insiders sold 125,402 shares of Arcutis Biotherapeutics Inc (ARQT) in total and bought 0 shares, with a net sale of 125,402 shares. During the past 18 months, 224,195 shares of Arcutis Biotherapeutics Inc (ARQT) were sold and 102,515 shares were bought by its insiders, resulting in a net sale of 121,680 shares.
Arcutis Biotherapeutics Inc (ARQT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Arcutis Biotherapeutics Inc Insider Transactions
John W Smither Mailing Address
Above is the net worth, insider trading, and ownership report for John W Smither. You might contact John W Smither via mailing address: C/o Kythera Biopharmaceuticals, Inc., 27200 West Agoura Road, Suite 200, Calabasas Ca 91301.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
